Evercore ISI Group analyst Thomas Gallagher maintains Equitable Holdings (NYSE:EQH) with a Outperform and lowers the price target from $45 to $41.
Global Coalition For Adaptive Research, Biohaven, And Vigeo Announce Commencement Of Biohaven’s Troriluzole And Vigeo’s VT1021 In GBM AGILE Trial
Global Coalition for Adaptive Research, Biohaven, and Vigeo Announce Commencement of Biohaven's Troriluzole and Vigeo'S VT1021 in GBM AGILE Trial
Biohaven and Vigeo Now Enrolling in GBM AGILE, Registrational